Papillary Thyroid Cancer

An ADENOCARCINOMA that originates from follicular cells of the THYROID GLAND and accounts for the majority of THYROID CANCER cases. Cells exhibit enlarged, oval, or elongated morphologies with clear, round, nuclei. Fusions of RET, NTRK1, TPM3, and PCM1 genes are associated with this cancer.

Also Known As:

Thyroid Cancer, Papillary; Familial Nonmedullary Thyroid Cancer; Nonmedullary Thyroid Carcinoma; Papillary Carcinoma Of Thyroid; Papillary Thyroid Carcinoma; Thyroid Carcinoma, Papillary; Cancer, Papillary Thyroid; Cancers, Papillary Thyroid; Carcinoma, Nonmedullary Thyroid; Carcinoma, Papillary Thyroid; Carcinomas, Nonmedullary Thyroid; Carcinomas, Papillary Thyroid; Nonmedullary Thyroid Carcinomas; Papillary Thyroid Cancers; Papillary Thyroid Carcinomas; Thyroid Cancers, Papillary; Thyroid Carcinoma, Nonmedullary; Thyroid Carcinomas, Nonmedullary; Thyroid Carcinomas, Papillary

Neoplasms: 1361496
- Neoplasms by Site: 4
  - Head and Neck Neoplasms: 18631
    - Thyroid Neoplasms: 18499
      - Papillary Thyroid Cancer: 6133
  - Endocrine Gland Neoplasms: 135
    - Thyroid Neoplasms: 18499
      - Papillary Thyroid Cancer: 6133
- Neoplasms by Histologic Type: 2
  - Glandular and Epithelial Neoplasms: 445
    - Carcinoma: 143226
      - Adenocarcinoma: 59622
        Papillary Adenocarcinoma: 295
        Papillary Thyroid Cancer: 6133
Endocrine System Diseases: 996
- Thyroid Diseases: 6248
  - Thyroid Neoplasms: 18499
    - Papillary Thyroid Cancer: 6133
- Endocrine Gland Neoplasms: 135
  - Thyroid Neoplasms: 18499
    - Papillary Thyroid Cancer: 6133

Maziar Motiee Selected Research

Maziar Motiee Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure